» Authors » Lydia G van der Geest

Lydia G van der Geest

Explore the profile of Lydia G van der Geest including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 222
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gehrels A, Vissers P, Sprangers M, Fijnheer N, Pijnappel E, van der Geest L, et al.
EClinicalMedicine . 2025 Feb; 80:103068. PMID: 39902316
Background: Pancreatic adenocarcinoma (PAC) has a poor prognosis and substantially impairs health-related quality of life (HRQoL). Large studies on longitudinal HRQoL in patients with PAC, taking patient treatment into account,...
2.
Kuijper S, Gehrels A, van der Geest L, Verhoeven R, Groot Koerkamp B, Molenaar I, et al.
Int J Cancer . 2024 Nov; 156(9):1726-1735. PMID: 39614657
Pancreatic adenocarcinoma (PAC) is notorious for its poor survival. The provision of survival scenarios-that is, best-case, typical and worst-case scenarios-could prove valuable to patients and clinicians. This study investigated survival...
3.
Furumaya A, van Delden O, de Wilde R, de Vos-Geelen J, van der Geest L
Disaster Med Public Health Prep . 2024 Oct; 18:e243. PMID: 39473387
Objective: The impact of the coronavirus disease 2019 (COVID-19) on hepatocellular carcinoma (HCC) care is unclear. This study reports on HCC patterns during the COVID-19 pandemic in the Netherlands. Methods:...
4.
Mackay T, Latenstein A, Augustinus S, van der Geest L, Bogte A, Bonsing B, et al.
JAMA Surg . 2024 Feb; 159(4):429-437. PMID: 38353966
Importance: Implementation of new cancer treatment strategies as recommended by evidence-based guidelines is often slow and suboptimal. Objective: To improve the implementation of guideline-based best practices in the Netherlands in...
5.
Olthof P, Franssen S, van Keulen A, van der Geest L, Hoogwater F, Coenraad M, et al.
HPB (Oxford) . 2023 Aug; 25(11):1329-1336. PMID: 37532665
Background: Most data on the treatment and outcomes of intrahepatic cholangiocarcinoma (iCCA) derives from expert centers. This study aimed to investigate the treatment and outcomes of all patients diagnosed with...
6.
Hopstaken J, Vissers P, Quispel R, de Vos-Geelen J, Brosens L, de Hingh I, et al.
BJS Open . 2023 May; 7(3). PMID: 37151083
Background: Centralization of pancreatic cancer surgery aims to improve postoperative outcomes. Consequently, patients with pancreatic cancer may undergo pancreatic surgery in an expert centre and adjuvant chemotherapy in a local...
7.
Rijken A, Bakkers C, Klumpen H, van der Geest L, de Vos-Geelen J, van Erning F, et al.
Eur J Surg Oncol . 2023 Mar; 49(8):1436-1443. PMID: 36898900
Introduction: - This population-based study aimed to investigate incidence, risk factors, treatment, and survival of synchronous peritoneal metastases (PM) of hepatobiliary origin. Methods: - All Dutch patients diagnosed with hepatobiliary...
8.
Klatte D, Boekestijn B, Onnekink A, Dekker F, van der Geest L, Wasser M, et al.
Gastroenterology . 2023 Mar; 164(7):1223-1231.e4. PMID: 36889551
Background & Aims: Recent pancreatic cancer surveillance programs of high-risk individuals have reported improved outcomes. This study assessed to what extent outcomes of pancreatic ductal adenocarcinoma (PDAC) in patients with...
9.
Hopstaken J, Vissers P, Quispel R, de Vos-Geelen J, Brosens L, de Hingh I, et al.
Eur J Surg Oncol . 2022 Jun; 48(10):2195-2201. PMID: 35701256
Background: Due to the centralization of pancreatic surgery, patients with suspected pancreatic cancer may undergo diagnostic workup in both a non-pancreatic centre and a pancreatic centre, i.e. multicentre workup. This...
10.
de Jong E, Mommers I, Sarasqueta A, van der Geest L, Heij L, de Hingh I, et al.
Acta Oncol . 2022 Apr; 61(5):591-596. PMID: 35382678
No abstract available.